about
Animal models of heart failure with preserved ejection fractionTargeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of CardiologyRemote ischemic conditioning in ST-elevation myocardial infarction as adjuvant to primary angioplasty (RIC-STEMI): study protocol for a randomized controlled trialCurrent pathophysiological concepts and management of pulmonary hypertension.Physiological, pathological and potential therapeutic roles of adipokines.Pivotal role of microRNAs in cardiac physiology and heart failure.ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models.Levosimendan: The current situation and new prospects.Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome.Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice.A high-calorie diet attenuates cachexia and adipose tissue inflammation in monocrotaline-induced pulmonary hypertensive rats.Comparison of different methods of heart rate entropy analysis during acute anoxia superimposed on a chronic rat model of pulmonary hypertension.Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension.Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension.Dose-Response Head-to-Head Comparison of Inodilators Dobutamine, Milrinone, and Levosimendan in Chronic Experimental Pulmonary Hypertension.Contractile effects of Ghrelin and expression of its receptor GHS-R1a in normal and hypertrophic myocardium.Right ventricular end-diastolic stiffness heralds right ventricular failure in monocrotaline-induced pulmonary hypertension.An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.Spectral transfer function analysis of respiratory hemodynamic fluctuations predicts end-diastolic stiffness in preserved ejection fraction heart failure.Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction.Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study.Myocardial and anti-inflammatory effects of chronic bosentan therapy in monocrotaline-induced pulmonary hypertension.Prospective randomised comparison of Marsh and Schnider pharmacokinetic models for propofol during induction of anaesthesia in elective cardiac surgery.Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension.Improvement in left intraventricular pressure gradients after aortic valve replacement in aortic stenosis patients.Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats.Freedom Solo® versus Trifecta® bioprostheses: clinical and haemodynamic evaluation after propensity score matching.Chronic exercise induces pathological left ventricular hypertrophy in adrenaline-deficient mice.Remote myocardium gene expression after 30 and 120 min of ischaemia in the rat.Early and mid-term haemodynamic performance and clinical outcomes of St. Jude Medical Trifecta™ valve.Stretch-induced compliance: a novel adaptive biological mechanism following acute cardiac load.Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.Survival after bilateral internal mammary artery in coronary artery bypass grafting: Are women at risk?Hemodynamic and clinical performance of Solo stentless bioprosthetic aortic valvesMyocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk ModelNeuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertensionGhrelin reverses molecular, structural and hemodynamic alterations of the right ventricle in pulmonary hypertensionCardiac remodeling and dysfunction in nephrotic syndromeA Western-type diet attenuates pulmonary hypertension with heart failure and cardiac cachexia in rats.Acute changes of biventricular gene expression in volume and right ventricular pressure overload
P50
Q26764971-4F284004-739F-4959-A4EB-EC4D3DB1FDF8Q27024879-7A665D6A-908E-4E42-841C-6E327B56F2A5Q36040821-CA28283A-91EF-4202-B94E-5EA9E70C2F67Q37884873-1BB99F81-7ADC-4807-8606-61699D56BCF3Q38007838-C31E92D4-C824-4B32-B93D-44975C2B4E16Q38129639-61D89F74-E3AD-4D35-A0E2-A7BF4CE85B84Q38191520-227C1C59-8F87-48AA-9B0E-981503C48C0EQ38280391-A37144B2-96CC-437A-9A79-16D516E49DC0Q38287982-1498027C-B335-48A9-A6E9-F9EA03F62309Q42441069-60E5BCEC-8AFE-4DDF-913E-B624002E575BQ42968607-07A254ED-6E45-43FA-B7CD-D95B1F389713Q43755486-1220AC83-99ED-46D3-B3FE-8476E04BEDF3Q45032146-F5A39F89-D8C9-40D5-85F9-B7B2EB38EFA7Q46087525-6E33EC8C-601C-4C02-A646-643DAA832D19Q46586833-94101090-874B-4774-B078-AA25FB95121FQ46883498-401B28FE-D76D-416C-A028-270B3C6C95C0Q46980824-3F7EDED2-A3B3-47AB-8D7C-F5E2ED3D1025Q47338830-B1C53FB0-5384-45AF-AE50-06C3374709C8Q47638072-B4AFA9AB-F7C9-41B4-BBA5-E76C0B1F7536Q47648074-7222E3FA-309A-4CF6-AE97-3FEE04C3A4F0Q47722872-CC13B102-ABA2-41AC-8F85-C10D0D862E61Q47877769-CE44CDD8-7CA0-4A5D-A5CB-FE379222CA8AQ48134568-2FDF9F45-E7E4-4DEE-8125-A6F14C31E9A3Q48185493-FA5AAFF5-C67B-4CF5-9942-81DC0D6CE1E7Q48241691-29983050-EC41-4A06-8513-19A27D2DB910Q48552138-E4FE7A5B-CEBE-414B-82A5-060CE84E3E3DQ49916631-4BB78330-5491-46EF-90F8-7D186A80FF69Q50117416-81477D00-456B-4209-A120-11C693425450Q50481647-F4AF1C84-61AA-45DC-AB23-C0C7BEA6F7CDQ52614481-4B3CD2F9-915B-4350-A2B3-D73D74374A30Q52699625-C95F9905-0D63-4C6C-862B-65BC296A93DCQ53127227-FCA088E1-4892-4DB4-91D5-A62E1CC53AD1Q56761526-A1218BC8-C04A-4D08-9208-20AD6DDB8E6EQ57067655-110614F3-3BAF-461E-9DFF-D78D631D87D4Q57395335-4669E544-A3E9-44BF-81A2-9E5D8670A55DQ57805025-8EEB9620-C4E9-4FC7-999C-6F8EBB11CF49Q57912877-EE658CE7-3C5D-42DB-B3B6-DB26ED08744EQ58930288-2D25C5BC-8617-42AF-A1C7-AB514E64170DQ64988261-54DB3CAB-E9B3-4218-9666-CDCD852D75BDQ81535466-BC3CBC25-176B-4F02-BBFB-808F689C4612
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
André P. Lourenço
@ast
André P. Lourenço
@en
André P. Lourenço
@es
André P. Lourenço
@nl
type
label
André P. Lourenço
@ast
André P. Lourenço
@en
André P. Lourenço
@es
André P. Lourenço
@nl
altLabel
A Lourenço
@en
prefLabel
André P. Lourenço
@ast
André P. Lourenço
@en
André P. Lourenço
@es
André P. Lourenço
@nl
P1053
E-5878-2011
P106
P1153
35902524200
P21
P31
P3829
P496
0000-0002-5756-9535